Stefano Severi

4PUBLICATIONS
23CO-AUTHORS
Radiation therapyPredictive and prognostic markersPharmaceutical delivery technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Irene Marini, Emilio Francesco Giunta, Silvia Nicolini

|Dec 23, 2022
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials.

Alberto Bongiovanni, Silvia Nicolini, Toni Ibrahim

|Jul 09, 2022
Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials.

Valentina Di Iorio, Stefano Boschi, Cristina Cuni

|Jul 09, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.

Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca

Pageof 1

Frequent Collaborators

3 joint publications

Flavia Foca

2 joint publications

Nicoletta Ranallo

2 joint publications

Chiara Calabrese

2 joint publications

Maddalena Sansovini